Contralateral breast cancer risk in irradiated breast cancer patients with a germline-BRCA1/2 pathogenic variant. van Barele M, Akdeniz D, Heemskerk-Gerritsen BAM, Andrieu N, et al. J Natl Cancer Inst 2023 Jun 27:djad116. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

van Barele M, Akdeniz D, Heemskerk-Gerritsen BAM, Andrieu N, et al. Contralateral breast cancer risk in irradiated breast cancer patients with a germline-BRCA1/2 pathogenic variant. J Natl Cancer Inst 2023 Jun 27:djad116. doi: 10.1093.
PMID: 37369040